CSF3R mutations have a high degree of overlap with CEBPA mutations in pediatric AML.

Publisher's Note: There is an [Inside Blood Commentary][1] on this article in this issue. To the editor: Childhood cancers represent distinct clinical entities, often with unique genomic alterations and therapeutic responses that differ from cancers arising in adults. Pediatric acute myeloid